2022
DOI: 10.3389/fonc.2022.963469
|View full text |Cite
|
Sign up to set email alerts
|

Retinal hemangioblastoma in a patient with Von Hippel-Lindau disease: A case report and literature review

Abstract: BackgroundRetinal hemangioblastoma (RH) is a rare benign tumor and a considerable number of which are caused by Von Hippel-Lindau disease (VHL). Herein, we described a case of VHL-associated RH with retinal detachment who underwent both laser photocoagulation and vitreoretinal surgery and received satisfactory visual recovery. In addition, we reviewed the current diagnosis, genotype-phenotype association, and treatment of VHL-associated RH.Case descriptionA 34-year-old woman presented with vision loss in the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…PCCs/PGLs are more common in some subtypes of VHL. Type 1 is associated with missense and truncating mutations that grossly disrupt the folding of the VHL protein, has the lowest risk of less than 5% for PCCs, and is associated with retinal hemangioblastoma, central nervous system hemangioblastoma, renal cell carcinoma, pancreatic cysts, and neuroendocrine tumors such as PGLs ( 2 , 4 , 14 , 25 ). Our patient with a genetic mutation of p.N78S (c.233A>G) is most likely to have VHL type 1.…”
Section: Discussionmentioning
confidence: 99%
“…PCCs/PGLs are more common in some subtypes of VHL. Type 1 is associated with missense and truncating mutations that grossly disrupt the folding of the VHL protein, has the lowest risk of less than 5% for PCCs, and is associated with retinal hemangioblastoma, central nervous system hemangioblastoma, renal cell carcinoma, pancreatic cysts, and neuroendocrine tumors such as PGLs ( 2 , 4 , 14 , 25 ). Our patient with a genetic mutation of p.N78S (c.233A>G) is most likely to have VHL type 1.…”
Section: Discussionmentioning
confidence: 99%
“…All patients affected by VHL, and their at-risk relatives should undergo regular annual eye examinations starting in childhood, including visual acuity testing, fundus examination, fundus photography, and fluorescence angiography. The purpose of this diagnosis is to ensure early diagnosis and the implementation of prompt treatment [8,9]. Magnetic resonance imaging (MRI) is the preferred imaging modality for brain and whole nervous system tumor lesions in VHL syndrome, as it provides better imaging quality compared to computed tomography (CT) and other modalities.…”
Section: Introductionmentioning
confidence: 99%